Efficacy data include Hb, HbA1c, hematocrit, total body weight, sitting systolic and diastolic blood pressure, sitting heart rate, eGFR, urine albumin/creatinine ratio, and the proportion of patients with changes in anemia status from baseline to week 24. Here, GSTM1 is linked to anemia.